How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2367
https://www.valueinhealthjournal.com/article/S1098-3015(16)33733-0/fulltext
Title :
How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33733-0&doi=10.1016/j.jval.2016.09.2367
First page :
A761
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2247